Trials / Terminated
TerminatedNCT00364689
RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effectiveness of three different treatments for hepatic encephalopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rifaximin | |
| DRUG | Lactulose | |
| OTHER | Placebo |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2006-08-16
- Last updated
- 2019-09-17
- Results posted
- 2019-09-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00364689. Inclusion in this directory is not an endorsement.